Actively Recruiting
Impact of Psychomotor Therapy on the Quality of Life in Depression
Led by Centre Hospitalier Esquirol · Updated on 2025-02-19
128
Participants Needed
1
Research Sites
121 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Esquirol
Lead Sponsor
D
Direction Générale de l'Offre de Soins
Collaborating Sponsor
AI-Summary
What this Trial Is About
The effectiveness of psychomotor therapy in improving clinical outcomes or quality of life for individuals with depression is unclear. The investigators will assess how the participants' quality of life and psychomotor profile change over time. The study aims to compare the quality of life at 3 months between patients who received 3 months of personalised psychomotor therapy in addition to standard treatment and those who received standard treatment alone. The study lasted for 6 months, and the investigators expects a total of 128 people to participate in this research across several hospital establishments. This study evaluates the effectiveness of two types of treatment, divided into two randomly selected groups. To participate, individuals must have a medical diagnosis of major depressive disorder (MDD) and be between the ages of 20 and 60. They must have depressive symptoms with an HDRS score greater than 16 and provide informed consent. They must be treated or hospitalised at the Centre Hospitalier Esquirol or the Centre Hospitalier Henri Laborit (France). After providing consent, they will undergo an initial clinical interview that evaluates anxiety, self-esteem, pleasure, and quality of life. The therapist assessed the participant's muscle tone, gross motor skills, praxis, manual dexterity, rhythm, processing of sensory information, and body image. Following the assessment, the participant was randomly assigned to either the experimental or control group. The experimental group received the usual treatment for depression and underwent psychomotor therapy once a week for 12 weeks. The control group received the standard treatment for depression and underwent weekly telephone interviews. An assessment is scheduled at 1 month to evaluate the participant's health status, including any changes to treatment and assessment of anxiety and depressive symptoms. Another interim check-up is scheduled at 3 months to assess the patient's health status. The interview will also assess any changes to treatment, anxiety and depressive symptoms, quality of life, and psychomotor function. A final visit will be scheduled at 6 months for an assessment of the participant's health. The interview will also assess any changes to treatment, anxiety and depressive symptoms, quality of life, and psychomotor function.
CONDITIONS
Official Title
Impact of Psychomotor Therapy on the Quality of Life in Depression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of depressive episode according to DSM-5 criteria
- Hamilton Depression Rating Scale (HDRS) score greater than 16
- Hospitalized or followed-up in one of the participating centers
- Affiliated with or beneficiary of a social security scheme
- Free, informed, and written consent signed by the participant and investigator before any research examination
You will not qualify if you...
- Psychiatric comorbidity excluding tobacco addiction, eating disorders, bipolar disorder, obsessive-compulsive disorder, schizophrenia, and related disorders
- Sensory impairment or proven neurological pathology
- History of neurological brain damage such as stroke, tumor, or trauma causing loss of consciousness over 10 minutes
- Limited functional ability affecting movement or manual tasks
- Inability to understand questionnaires and study information
- Inability to travel to the inclusion center by personal vehicle or public transport
- Pregnant or breastfeeding women (self-declared)
- Forced hospitalization, subjects under guardianship or trusteeship
- Lack of social protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CH Esquirol
Limoges, France, 87000
Actively Recruiting
Research Team
A
Aude PAQUET, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here